CytomX Therapeutics
CTMX
CTMX
141 hedge funds and large institutions have $843M invested in CytomX Therapeutics in 2018 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 42 increasing their positions, 43 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 43
1.44% less ownership
Funds ownership: 78.49% → 77.05% (-1.4%)
Holders
141
Holding in Top 10
2
Calls
$2.72M
Puts
$177K
Top Buyers
| 1 | +$69.5M | |
| 2 | +$10.4M | |
| 3 | +$7.48M | |
| 4 |
Renaissance Technologies
New York
|
+$7M |
| 5 |
PC
PointState Capital
New York
|
+$4.38M |
Top Sellers
| 1 | -$65.4M | |
| 2 | -$23.7M | |
| 3 | -$8.01M | |
| 4 |
Millennium Management
New York
|
-$6.9M |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$4.19M |